- 英文名称
- Dolutegravir
- 分子式
- C20H19F2N3O5
- 分子量
- 419.38
- 中文别名
- (4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氢-7-羟基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]噁嗪-9-甲酰胺; 度鲁特韦游离酸; 德罗特韦; 杜鲁特韦; (4R,12aS)-N-(2,4-二氟苄基)-7-羟基-4-甲基-6,8-二氧代-3,4,6,8,12,12a-六氢-2H-吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]恶嗪-9-甲酰胺; GSK1349572; Dolutegravir API; 2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-; (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide; S-349572; Dolutegravir free acid; GSK 1349572; Tivicay
- 用途
- 度鲁特韦(dolutegravir,DTG),商品名:TIVICAY,是HIV-1整合酶链转移抑制药(INSTI),用于与其他抗逆转录病毒药联用治疗成年及12岁以上和体质量至少40kg儿童的HIV-1感染。